Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Å©·Ðº´ ȯÀÚ¿¡°Ô ¾ÆÀÚƼ¿ÀÇÁ¸° Ä¡·á Áß ¹ß»ýÇÑ ºñ°æÈ­¼º ¹®¸Æ °íÇ÷¾Ð 1¿¹ Azathioprine-Induced Non-Cirrhotic Portal Hypertension in a Patient with Crohn¡¯s Disease

´ëÇѳ»°úÇÐȸÁö 2020³â 95±Ç 2È£ p.119 ~ 123
¹Ú¹Î±Ô, ÀÌÀ籤, ±èÇö¼ö, Á¤À±Áø, ¹Úâ±Ù, Á¤Àç±Ç, ±è´ëÁø,
¼Ò¼Ó »ó¼¼Á¤º¸
¹Ú¹Î±Ô ( Park Min-Kyu ) 
´ë±¸ÆÄƼ¸¶º´¿ø ¼ÒÈ­±â³»°ú

ÀÌÀ籤 ( Lee Jae-Kwang ) 
´ë±¸ÆÄƼ¸¶º´¿ø ¼ÒÈ­±â³»°ú
±èÇö¼ö ( Kim Hyun-Soo ) 
´ë±¸ÆÄƼ¸¶º´¿ø ¼ÒÈ­±â³»°ú
Á¤À±Áø ( Chung Yun-Jin ) 
´ë±¸ÆÄƼ¸¶º´¿ø ¼ÒÈ­±â³»°ú
¹Úâ±Ù ( Park Chang-Keun ) 
´ë±¸ÆÄƼ¸¶º´¿ø ¼ÒÈ­±â³»°ú
Á¤Àç±Ç ( Jung Jae-Kwon ) 
´ë±¸ÆÄƼ¸¶º´¿ø ¼ÒÈ­±â³»°ú
±è´ëÁø ( Kim Dae-Jin ) 
´ë±¸ÆÄƼ¸¶º´¿ø ¼ÒÈ­±â³»°ú

Abstract


Thiopurine-based drugs such as azathioprine and 6-MP are among the most common immunosuppressants used to treat inflammatory bowel disease, autoimmune hepatitis, various autoimmune diseases, and patients undergoing organ transplantation. The drugs are associated with various complications, of which one of the most serious is hepatotoxicity that may trigger non-cirrhotic portal hypertension. We report a case with this side-effect in a patient taking azathioprine to treat Crohn¡¯s disease.

Å°¿öµå

Azathioprine; Hypertension, Portal; Nodular regenerative hyperplasia

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS